Argus•November 18, 2020

NEO: Raising target price to $46.00

Symbols

NEO

Sector(s)

Healthcare

Rating

Premium

Current Price

$55.57

Price Target

$NaN

Earnings Estimate

Premium

Summary

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland.

Premium

Subscribe to Yahoo Finance Premium for full access

Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.

Try Premium FREE

Actions

Download Full Report

Related Reports

DVA: Lowering target price to $130.00
Jan 20, 2021 •
DVA
GKOS: Raising target price to $71.00
Jan 20, 2021 •
GKOS
Analyst Report: Laboratory Corporation of America Holdings
Jan 15, 2021 •
LH
DVA: Raising target price to $135.00
Jan 13, 2021 •
DVA
GKOS: Raising target price to $66.00
Jan 13, 2021 •
GKOS

View more related reports